Cardiff Lexington ^{Filed, US Offering, Nasdaq: CDIX}

Our company is a targeted healthcare holding company dedicated to acquiring and building middle-market niche health care clinics, primarily in orthopedics, spine care, and pain management. Our partnership-driven culture emphasizes service excellence, teamwork, accountability, and performance. We have a geographic specific acquisition strategy driven by targeted M&A execution across three synergistic complementary pillars: Core Cash Flow – Acquiring, optimizing, and managing physician practices to drive recurring revenue and operational efficiency; Asset Acquisition – Expanding our footprint through ownership of real estate assets such as ambulatory surgery centers and orthopedic clinics; Finance – Retaining and managing personal injury practice accounts receivable to capture long-term income rather than selling at deep discounts, strengthening sustainable profitability. We are focused on the acquisition of orthopedic and related modality practices with strong organic growth plans that are materially cash generative to maximize value and providing greater coverage for our patients, and diversification and risk mitigation for our stockholders. All current revenue is derived from Nova Ortho and Spine, LLC, or Nova, which was acquired on May 31, 2021.